ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer

Guotai Xu(Memorial Sloan Kettering Cancer Center), Sagar Chhangawala(Memorial Sloan Kettering Cancer Center), Emiliano Cocco(Memorial Sloan Kettering Cancer Center), Pedram Razavi(Memorial Sloan Kettering Cancer Center), Yanyan Cai(Memorial Sloan Kettering Cancer Center), Jordan E. Otto(Harvard University), Lorenzo Ferrando(Memorial Sloan Kettering Cancer Center), Pier Selenica(Memorial Sloan Kettering Cancer Center), Erik Ladewig(Memorial Sloan Kettering Cancer Center), Carmen Chan(Memorial Sloan Kettering Cancer Center), Arnaud Da Cruz Paula(Memorial Sloan Kettering Cancer Center), Matthew D. Witkin(Memorial Sloan Kettering Cancer Center), Yuanming Cheng(Memorial Sloan Kettering Cancer Center), Jane Park(Memorial Sloan Kettering Cancer Center), Cristian Serna‐Tamayo(Memorial Sloan Kettering Cancer Center), HuiYong Zhao(Memorial Sloan Kettering Cancer Center), Fan Wu(Memorial Sloan Kettering Cancer Center), Mirna Sallaku(Memorial Sloan Kettering Cancer Center), Xuan Qu(Memorial Sloan Kettering Cancer Center), Alison Zhao(Memorial Sloan Kettering Cancer Center), Clayton K. Collings(Broad Institute), Andrew R. D’Avino(Broad Institute), Komal Jhaveri(Memorial Sloan Kettering Cancer Center), Richard P. Koche(Memorial Sloan Kettering Cancer Center), Ross L. Levine(Memorial Sloan Kettering Cancer Center), Jorge S. Reis‐Filho(Memorial Sloan Kettering Cancer Center), Cigall Kadoch(Broad Institute), Maurizio Scaltriti(Memorial Sloan Kettering Cancer Center), Christina S. Leslie(Memorial Sloan Kettering Cancer Center), José Baselga(Memorial Sloan Kettering Cancer Center), Eneda Toska(Memorial Sloan Kettering Cancer Center)
Nature Genetics
January 13, 2020
Cited by 238Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis